Genmab As Stock Pattern Recognition Doji Star

GMAB Stock  USD 20.65  0.18  0.88%   
Genmab AS pattern recognition tool provides the execution environment for running the Doji Star recognition and other technical functions against Genmab AS. Genmab AS value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of pattern recognition indicators. As with most other technical indicators, the Doji Star recognition function is designed to identify and follow existing trends. Genmab AS momentum indicators are usually used to generate trading rules based on assumptions that Genmab AS trends in prices tend to continue for long periods.

Recognition
The output start index for this execution was eleven with a total number of output elements of fifty. The function generated a total of one valid pattern recognition events for the selected time horizon. Doji Star may indicate a high probability reversal condition for Genmab AS.

Genmab AS Technical Analysis Modules

Most technical analysis of Genmab AS help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Genmab from various momentum indicators to cycle indicators. When you analyze Genmab charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Genmab AS Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Genmab AS. We use our internally-developed statistical techniques to arrive at the intrinsic value of Genmab AS based on widely used predictive technical indicators. In general, we focus on analyzing Genmab Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Genmab AS's daily price indicators and compare them against related drivers, such as pattern recognition and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Genmab AS's intrinsic value. In addition to deriving basic predictive indicators for Genmab AS, we also check how macroeconomic factors affect Genmab AS price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2021 2022 2023 2024 (projected)
Days Sales Outstanding146.22142.85109.61104.13
PTB Ratio7.757.014.455.55
Hype
Prediction
LowEstimatedHigh
19.2520.7122.17
Details
Intrinsic
Valuation
LowRealHigh
18.5927.1228.58
Details
Naive
Forecast
LowNextHigh
18.6020.0621.52
Details
9 Analysts
Consensus
LowTargetHigh
40.7544.7849.71
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Genmab AS. Your research has to be compared to or analyzed against Genmab AS's peers to derive any actionable benefits. When done correctly, Genmab AS's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Genmab AS.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Genmab AS in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Genmab AS's short interest history, or implied volatility extrapolated from Genmab AS options trading.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Entertainment Idea
Entertainment
Invested over 90 shares
Macroaxis Index Idea
Macroaxis Index
Invested few shares
Hedge Favorites Idea
Hedge Favorites
Invested over 60 shares
Impulse Idea
Impulse
Invested over 100 shares
Banking Idea
Banking
Invested over 20 shares
FinTech Idea
FinTech
Invested over 40 shares
Corona Opportunity Idea
Corona Opportunity
Invested few shares
Driverless Cars Idea
Driverless Cars
Invested few shares
Dividend Beast Idea
Dividend Beast
Invested over 50 shares
Chemicals Idea
Chemicals
Invested over 30 shares
Business Services Idea
Business Services
Invested few shares
Macroaxis Picks Idea
Macroaxis Picks
Invested over 30 shares
Baby Boomer Prospects Idea
Baby Boomer Prospects
Invested over 60 shares
Momentum Idea
Momentum
Invested few shares
When determining whether Genmab AS offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Genmab AS's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Genmab As Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Genmab As Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Genmab AS. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
For information on how to trade Genmab Stock refer to our How to Trade Genmab Stock guide.
You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Genmab AS. If investors know Genmab will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Genmab AS listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.38)
Earnings Share
1.02
Revenue Per Share
30.6997
Quarterly Revenue Growth
0.176
Return On Assets
0.1095
The market value of Genmab AS is measured differently than its book value, which is the value of Genmab that is recorded on the company's balance sheet. Investors also form their own opinion of Genmab AS's value that differs from its market value or its book value, called intrinsic value, which is Genmab AS's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Genmab AS's market value can be influenced by many factors that don't directly affect Genmab AS's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Genmab AS's value and its price as these two are different measures arrived at by different means. Investors typically determine if Genmab AS is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Genmab AS's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.